Firnhaber JM, Powell CS. Lower extremity peripheral artery disease: diagnosis and treatment. Am Fam Physician. 2019;99(6):362–9.
PubMed
Google Scholar
Pourghaderi P, Yuquimpo KM, Roginski Guetter C, Mansfeld L, Park HS. Outcomes following lower extremity amputation in patients with diabetes mellitus and peripheral arterial disease. Ann Vasc Surg. 2020;63:259–68.
Article
Google Scholar
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.
Article
Google Scholar
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–53.
Article
Google Scholar
Beyond A1C Writing Group. Need for regulatory change to incorporate beyond A1C glycemic metrics. Diabetes Care. 2018;41(6):e92–4.
Article
Google Scholar
Shen Y, Zhou J, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, et al. Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes. Diabetes Obes Metab. 2020. Online ahead of print.
Koga M, Murai J, Morita S, Saito H, Kasayama S. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. J Diabetes Complications. 2013;27(3):211–3.
Article
Google Scholar
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.
Article
CAS
Google Scholar
National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Society, Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver diseases: a 2018 update. J Clin Hepatol. 2018;34(5):947–57.
Google Scholar
He XX, Su JR, Ma XJ, Lu W, Zhu W, Wang YF, et al. The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes. Cardiovasc Diabetol. 2020;19:40.
Article
CAS
Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
Article
Google Scholar
Sheng CS, Tian J, Miao Y, Cheng Y, Yang Y, Reaven PD, et al. Prognostic significance of longterm HbA1c variability for all-cause mortality in the ACCORD Trial. Diabetes Care. 2020;43(6):1185–90.
Article
CAS
Google Scholar
Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18(4):346–9.
Article
Google Scholar
Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816.
Article
Google Scholar
Cardoso CRL, Leite NC, Moram CBM, Salles GF, et al. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes The Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc Diabetol. 2018;17(1):33.
Article
CAS
Google Scholar
Ma X, Hu X, Zhou J, Hao Y, Luo Y, Lu Z, et al. Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c. Cardiovasc Diabetol. 2015;14:16.
Article
Google Scholar
Mihara A, Ohara T, Hata J, Honda T, Chen S, Sakata S, et al. Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: The Hisayama Study. Atherosclerosis. 2020;311:52–9.
Article
CAS
Google Scholar
Zhao X, Li Q, Tu C, Zeng Y, Ye Y. High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study. Cardiovasc Diabetol. 2020;19(1):171.
Article
CAS
Google Scholar
Jun JE, Lee SE, Lee YB, Ahn JY, Kim G, Jin SM, et al. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients. Cardiovasc Diabetol. 2017;16(1):127.
Article
Google Scholar
Park SB, Kim SS, Kim IJ, Nam YJ, Ahn KH, Kim JH, et al. Variability in glycated albumin levels predicts the progression of diabetic nephropathy. J Diabetes Complications. 2017;31(6):1041–6.
Article
Google Scholar
Chen CW, Drechsler C, Suntharalingam P, Karumanchi SA, Wanner C, Berg AH. High glycated albumin and mortality in persons with diabetes mellitus on hemodialysis. Clin Chem. 2017;63(2):477–85.
Article
CAS
Google Scholar
Hashimoto K, Osugi T, Noguchi S, Morimoto Y, Wasada K, Imai S, et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care. 2010;33(3):509–11.
Article
CAS
Google Scholar
Gorst C, Kwok CS, Aslam S, Buchan I, Kontopantelis E, Myint PK, et al. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38(12):2354–69.
Article
CAS
Google Scholar
Forbes A, Murrells T, Mulnier H, Sinclair AJ. Mean HbA, HbA variability, and mortality in people with diabetes aged 70 years and older a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(6):476–86.
Article
Google Scholar
Chang CM, Hsieh CJ, Huang JC, Huang IC. Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. 2012;49(Suppl 1):S171–7.
Article
Google Scholar
Wei F, Sun X, Zhao Y, Zhang H, Diao Y, Liu Z. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus. BMC Nephrol. 2016;17(1):67.
Article
Google Scholar
Schisano B, Tripathi G, McGee K, McTernan PG, Ceriello A. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011;54:1219–26.
Article
CAS
Google Scholar
Maciejewski ML, Dowd B, Call KT, Feldman R. Comparing mortality and time until death for medicare HMO and FFS beneficiaries. Health Serv Res. 2001;35:1245–65.
CAS
PubMed
PubMed Central
Google Scholar
Xu Y, Ma X, Shen Y, Wang Y, Zhou J, Bao Y. Increasing waist circumference is associated with decreased levels of glycated albumin. Clin Chim Acta. 2019;495:118–22.
Article
CAS
Google Scholar
Wang F, Ma X, Hao Y, Yang R, Ni J, Xiao Y, et al. Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance. PLoS ONE. 2012;711(11):e51098.
Article
Google Scholar
Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011;58(19):2020–45.
Article
Google Scholar